Literature DB >> 17607367

Neutrophil-mediated innate immune resistance to mycobacteria.

Adrian R Martineau1, Sandra M Newton, Katalin A Wilkinson, Beate Kampmann, Bridget M Hall, Niga Nawroly, Geoffrey E Packe, Robert N Davidson, Christopher J Griffiths, Robert J Wilkinson.   

Abstract

Neutrophils contain antimicrobial peptides with antituberculous activity, but their contribution to immune resistance to tuberculosis (TB) infection has not been previously investigated to our knowledge. We determined differential white cell counts in peripheral blood of 189 adults who had come into contact with patients diagnosed with active TB in London, United Kingdom, and evaluated them for evidence of TB infection and capacity to restrict mycobacterial growth in whole-blood assays. Risk of TB infection was inversely and independently associated with peripheral blood neutrophil count in contacts of patients diagnosed with pulmonary TB. The ability of whole blood to restrict growth of Mycobacterium bovis bacille Calmette Guérin and Mycobacterium tuberculosis was impaired 7.3- and 3.1-fold, respectively, by neutrophil depletion. In microbiological media, human neutrophil peptides (HNPs) 1-3 killed M. tuberculosis. The neutrophil peptides cathelicidin LL-37 and lipocalin 2 restricted growth of the organism, the latter in an iron-dependent manner. Black African participants had lower neutrophil counts and lower circulating concentrations of HNP1-3 and lipocalin 2 than south Asian and white participants. Neutrophils contribute substantially to innate resistance to TB infection, an activity associated with their antimicrobial peptides. Elucidation of the regulation of neutrophil antimicrobial peptides could facilitate prevention and treatment of TB.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17607367      PMCID: PMC1904316          DOI: 10.1172/JCI31097

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  32 in total

Review 1.  Benign ethnic neutropenia: what is a normal absolute neutrophil count?

Authors:  T B Haddy; S R Rana; O Castro
Journal:  J Lab Clin Med       Date:  1999-01

2.  Gamma interferon-based immunodiagnosis of tuberculosis: comparison between whole-blood and enzyme-linked immunospot methods.

Authors:  Elisabeth Schölvinck; Katalin A Wilkinson; Adam O Whelan; Adrian R Martineau; Michael Levin; Robert J Wilkinson
Journal:  J Clin Microbiol       Date:  2004-02       Impact factor: 5.948

3.  The mammalian ionic environment dictates microbial susceptibility to antimicrobial defense peptides.

Authors:  Robert A Dorschner; Belen Lopez-Garcia; Andreas Peschel; Dirk Kraus; Kazuya Morikawa; Victor Nizet; Richard L Gallo
Journal:  FASEB J       Date:  2006-01       Impact factor: 5.191

4.  Predictors of short-term prognosis in patients with pulmonary tuberculosis.

Authors:  P F Barnes; J M Leedom; L S Chan; S F Wong; J Shah; L A Vachon; G D Overturf; R L Modlin
Journal:  J Infect Dis       Date:  1988-08       Impact factor: 5.226

5.  Effect of BCG vaccination on risk of Mycobacterium tuberculosis infection in children with household tuberculosis contact: a prospective community-based study.

Authors:  Ahmet Soysal; Kerry A Millington; Mustafa Bakir; Davinder Dosanjh; Yasemin Aslan; Jonathan J Deeks; Serpil Efe; Imogen Staveley; Katie Ewer; Ajit Lalvani
Journal:  Lancet       Date:  2005 Oct 22-28       Impact factor: 79.321

6.  Depressed phagocytosis and oxidative burst in polymorphonuclear leukocytes from individuals with pulmonary tuberculosis with or without human immunodeficiency virus type 1 infection.

Authors:  S Shalekoff; C T Tiemessen; C M Gray; D J Martin
Journal:  Clin Diagn Lab Immunol       Date:  1998-01

7.  Influence of metal ions on the formation of mycobactin and salicylic acid in Mycobacterium smegmatis grown in static culture.

Authors:  C Ratledge; M J Hall
Journal:  J Bacteriol       Date:  1971-10       Impact factor: 3.490

8.  Cutting edge: 1,25-dihydroxyvitamin D3 is a direct inducer of antimicrobial peptide gene expression.

Authors:  Tian-Tian Wang; Frederick P Nestel; Véronique Bourdeau; Yoshihiko Nagai; Qiuyu Wang; Jie Liao; Luz Tavera-Mendoza; Roberto Lin; John W Hanrahan; Sylvie Mader; John H White; John H Hanrahan
Journal:  J Immunol       Date:  2004-09-01       Impact factor: 5.422

9.  Racial differences in susceptibility to infection by Mycobacterium tuberculosis.

Authors:  W W Stead; J W Senner; W T Reddick; J P Lofgren
Journal:  N Engl J Med       Date:  1990-02-15       Impact factor: 91.245

10.  IFN-gamma- and TNF-independent vitamin D-inducible human suppression of mycobacteria: the role of cathelicidin LL-37.

Authors:  Adrian R Martineau; Katalin A Wilkinson; Sandra M Newton; R Andres Floto; Anthony W Norman; Keira Skolimowska; Robert N Davidson; Ole E Sørensen; Beate Kampmann; Christopher J Griffiths; Robert J Wilkinson
Journal:  J Immunol       Date:  2007-06-01       Impact factor: 5.422

View more
  163 in total

1.  Human lung immunity against Mycobacterium tuberculosis: insights into pathogenesis and protection.

Authors:  Stephan Schwander; Keertan Dheda
Journal:  Am J Respir Crit Care Med       Date:  2010-11-12       Impact factor: 21.405

Review 2.  Mendelian randomization: potential use of genetics to enable causal inferences regarding HIV-associated biomarkers and outcomes.

Authors:  Weijing He; John Castiblanco; Elizabeth A Walter; Jason F Okulicz; Sunil K Ahuja
Journal:  Curr Opin HIV AIDS       Date:  2010-11       Impact factor: 4.283

Review 3.  Host-directed therapeutics for tuberculosis: can we harness the host?

Authors:  Thomas R Hawn; Alastair I Matheson; Stephen N Maley; Omar Vandal
Journal:  Microbiol Mol Biol Rev       Date:  2013-12       Impact factor: 11.056

4.  HIV-1 and the immune response to TB.

Authors:  Naomi F Walker; Graeme Meintjes; Robert J Wilkinson
Journal:  Future Virol       Date:  2013-01       Impact factor: 1.831

Review 5.  Immunological mechanisms contributing to the double burden of diabetes and intracellular bacterial infections.

Authors:  Kelly Hodgson; Jodie Morris; Tahnee Bridson; Brenda Govan; Catherine Rush; Natkunam Ketheesan
Journal:  Immunology       Date:  2015-02       Impact factor: 7.397

Review 6.  Early clearance of Mycobacterium tuberculosis: a new frontier in prevention.

Authors:  Ayesha J Verrall; Mihai G Netea; Bachti Alisjahbana; Philip C Hill; Reimout van Crevel
Journal:  Immunology       Date:  2014-04       Impact factor: 7.397

7.  Parallel in vivo experimental evolution reveals that increased stress resistance was key for the emergence of persistent tuberculosis bacilli.

Authors:  Aideen C Allen; Wladimir Malaga; Cyril Gaudin; Arnaud Volle; Flavie Moreau; Ali Hassan; Catherine Astarie-Dequeker; Antonio Peixoto; Rudy Antoine; Alexandre Pawlik; Wafa Frigui; Céline Berrone; Roland Brosch; Philip Supply; Christophe Guilhot
Journal:  Nat Microbiol       Date:  2021-07-22       Impact factor: 17.745

8.  Blood Cells and Interferon-Gamma Levels Correlation in Latent Tuberculosis Infection.

Authors:  Iukary Takenami; Camila Loureiro; Almério Machado; Krisztina Emodi; Lee W Riley; Sérgio Arruda
Journal:  ISRN Pulmonol       Date:  2013

9.  Prevalence and Determinants of QuantiFERON-Diagnosed Tuberculosis Infection in 9810 Mongolian Schoolchildren.

Authors:  Davaasambuu Ganmaa; Polyna Khudyakov; Uyanga Buyanjargal; Badamtsetseg Jargalsaikhan; Delgerekh Baigal; Oyunsuren Munkhjargal; Narankhuu Yansan; Sunjidmaa Bolormaa; Enkhsaikhan Lkhagvasuren; Christopher T Sempos; Sabri Bromage; Zhenqiang Wu; Batbayar Ochirbat; Batbaatar Gunchin; Adrian R Martineau
Journal:  Clin Infect Dis       Date:  2019-08-16       Impact factor: 9.079

10.  Immunomodulation with recombinant interferon-gamma1b in pulmonary tuberculosis.

Authors:  Rod Dawson; Rany Condos; Doris Tse; Maryann L Huie; Stanley Ress; Chi-Hong Tseng; Clint Brauns; Michael Weiden; Yoshihiko Hoshino; Eric Bateman; William N Rom
Journal:  PLoS One       Date:  2009-09-15       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.